| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.43 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |